Our advice for clinicians on the coronavirus is here.
If you are a member of the public looking for information and advice about coronavirus (COVID-19), including information about the COVID-19 vaccine, go to the NHS website. You can also find guidance and support on the GOV.UK website.
NHS England has today (Thursday 23 May, 2013) confirmed the designation of 15 new Academic Health Science Networks (AHSNs).
AHSNs have the potential to transform health and healthcare by putting innovation at the heart of the NHS. This will improve patient outcomes as well as contributing to economic growth.
AHSNs present a unique opportunity to pull together the adoption and spread of innovation with clinical research and trials, informatics, education, and healthcare delivery. They will develop solutions to healthcare problems and get existing solutions spread more quickly by building strong relationships with their regional scientific and academic communities and industry.
NHS England’s Chief Executive, Sir David Nicholson, said: “The NHS is full of brilliant people with brilliant ideas. To spread ideas right across the NHS means working collaboratively with all those who have an interest.
“AHSNs offer a more systematic delivery mechanism so that innovation spreads quickly and successfully through the NHS, making the best possible use of precious NHS resources and in ensuring the most advanced treatments, technologies and medicines are available to patients.”
The development of AHSNs was recommended in Sir David’s December 2011 report Innovation, Health and Wealth. Sir Alan Langlands, CEO of the Higher Education Funding Council, chaired the panel to consider applications from prospective AHSNs.
The 15 AHSNs they recommended will now be given licence to operate and will cover the whole of England.
They will work with all parts of the NHS and healthcare delivery partners to accelerate the adoption and spread of innovation Sir David added: “I am grateful to the Designation Panel for their work and recommendations. AHSNs have the potential to deliver transformational improvements in the quality and value of care provided in the NHS.”
Dame Sally Davies Chief Medical Officer said: “I am delighted the 15 AHSNs are now designated and licensed. They will have a major role in improving patient outcomes and population health right across the country through faster identification, adoption and spread of proven innovations and best practice. This will be achieved through collaboration within each AHSN and across AHSNs, and through working collaboratively with industry. This will also be achieved by the AHSNs promoting and supporting increased activity and performance of health research, which is delivered through the National Institute for Health Research.
“The AHSNs provide an important mechanism for achieving a step-change in the way the NHS translates research, innovation and best practice into effective and cost-effective treatments and services for patients.”
Earl Howe, Health Minister, said: “Britain is one of the best research centres in the world and it is important that we harness the skills and creativity in this sector to really improve the lives of those who use the NHS.
“The new AHSNs will help us develop better technology and make better use of the skills of NHS staff. They will also help us get in a better position to tackle the changing needs of our population and ensure patients get the care they deserve.”
The designated AHSNs are:
- East Midlands
- Greater Manchester
- North East and North Cumbria
- North West Coast
- Imperial College Health Partners
- South London
- South West Peninsula
- Kent, Surrey and Sussex
- UCL Partners
- West Midlands
- West of England
- Yorkshire and Humber